Default: Hematology/Oncology Clinics of North America

ISSN: 0889-8588

Journal Home

Journal Guideline

Hematology/Oncology Clinics of North America Q2 Unclaimed

W.B. Saunders United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hematology/Oncology Clinics of North America is a journal indexed in SJR in Hematology and Oncology with an H index of 95. It has an SJR impact factor of 0,705 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,705.

Hematology/Oncology Clinics of North America focuses its scope in these topics and keywords: treatment, approach, surgery, human, blood, tool, ultimate, emission, oncology, structure, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Hematology/Oncology Clinics of North America

0,705

SJR Impact factor

95

H Index

93

Total Docs (Last Year)

275

Total Docs (3 years)

5592

Total Refs

553

Total Cites (3 years)

238

Citable Docs (3 years)

2.29

Cites/Doc (2 years)

60.13

Ref/Doc

Comments

No comments ... Be the first to comment!

Other journals with similar parameters


Cytokine: X Q2
Cytokine Q2
Hematological Oncology Q2
Platelets Q2
Stem Cells and Development Q2

Compare this journals

Aims and Scope


treatment, approach, surgery, human, blood, tool, ultimate, emission, oncology, structure, prognosis, molecular, cytometry, bloodless, response, positron, tomography, erythropoietinflow, dyscrasiasthe, assessmentneurologic, approaches, ffluorodeoxyglucose, patientscombinatorial, melanomais, manifestations,



Best articles by citations

IMMUNOREGULATORY MECHANISMS IN MULTIPLE MYELOMA

View more

HIV-ASSOCIATED HODGKIN'S DISEASE

View more

CLINICAL ASPECTS OF APLASTIC ANEMIA

View more

ENDOCRINOPATHY AND ECTOPIC HORMONES IN MALIGNANCY

View more

PALLIATIVE MEDICINE AND THE MEDICAL ONCOLOGIST

View more

THERAPY-RELATED MYELOID LEUKEMIA

View more

HEMOLYTIC DISORDERS ASSOCIATED WITH CANCER

View more

CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY

View more

Treatment of Therapy-Related Acute Myelogenous Leukemia and Myelodysplastic Syndromes

View more

Pathology of Epithelial Tumors

View more

AUTOLOGOUS TRANSPLANTATION FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA

View more

MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SOLITARY PLASMACYTOMA

View more
SHOW MORE ARTICLES

INNOVATIVE THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA

View more

Early Diagnosis and Screening

View more

ETIOLOGY AND PATHOGENESIS OF AIDS-RELATED NON-HODGKIN'S LYMPHOMA

View more

CAN SCREENING FOR EARLY-STAGE PROSTATE CANCER BE RATIONALIZED?

View more

PULMONARY COMPLICATIONS

View more

INTRAEMBRYONIC HEMATOPOIETIC STEM CELLS

View more

BIOLOGY AND MANAGEMENT OF AIDS-ASSOCIATED PRIMARY CNS LYMPHOMAS

View more

BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES

View more

TARGETED THERAPY FOR LYMPHOMA WITH PEPTIDES

View more

MALIGNANT HISTIOCYTIC DISORDERS IN CHILDREN

View more

MALIGNANT HISTIOCYTOSIS

View more

PROGNOSTIC MARKERS IN RESECTABLE NON-SMALL CELL LUNG CANCER

View more

FAQS